Abstract
Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Mini-Reviews in Medicinal Chemistry
Title: Drug Targeting Strategies in Cancer Treatment: An Overview
Volume: 11 Issue: 1
Author(s): J. L. Arias
Affiliation:
Keywords: Active targeting, antitumor activity, cancer treatment, chemotherapy agent, colloidal drug delivery systems, controlled release, drug carrier, nanotoxicity, passive targeting, 5-fluorouracil, multi-drug resistance, reticuloendothelial system, mononuclear phagocyte system, opsonins, Doxorubicin, DOX-SLNs, caprolactone, tamoxifen, PLA-PEG, asialoglycoprotein, HepG2, monoclonal antibodies, Pseudomonas, PE38KDEL, Flow cytometry, confocal microscopy, Peptide-Mediated Targeting, Inulin multi-methacrylate (IMMA), CREKA, fibronectin, DAOY, vasoactive intestinal peptide, Integrin-Mediated Targeting, H2009, Aptamer-Mediated Targeting, PSMA, LNCaP xenograft, Folate Receptor Targeting, HeLa, paclitaxel prodrug, Cremophor, prodrug therapy, TRAIL immunotherapy, Transferrin Receptor Targeting, fluorescence microscopic, EGFR, acute myeloid leukemia, hyperthermia, Thermo-sensitive magnetoliposomes, methotrexate, Magnetic Drug Targeting, Ultrasound-Mediated Drug Delivery, Low frequency ultrasound, metalloproteinase-2, PEGylation, paclitaxel, tariquidar, Myocet, Doxil, Caelyx, Genexol-PM
Abstract: Classic chemotherapy has little or no specificity for cancer cells, normally resulting in low accumulation at the tumor region (inefficacy), and in severe side effects (toxicity). This challenge has resulted in the development of several delivery strategies for chemotherapy agents to improve their concentration at the tumor site, simultaneously increasing their anticancer efficacy, while reducing the associated adverse systemic effects. In this work, the potential of drug delivery strategies involving the use of nanocarriers for controlling the biodistribution of antitumor drugs is deeply revised: passive targeting (through the enhanced permeability and retention effect, EPR effect) and active targeting (including stimuli-sensitive carriers and ligand-mediated delivery). Special attention will be also focussed on the recent approaches for overcoming multi-drug resistance. Finally, a general view of the problem of “nanotoxicity” in cancer treatment is also given.
Export Options
About this article
Cite this article as:
L. Arias J., Drug Targeting Strategies in Cancer Treatment: An Overview, Mini-Reviews in Medicinal Chemistry 2011; 11 (1) . https://dx.doi.org/10.2174/138955711793564024
DOI https://dx.doi.org/10.2174/138955711793564024 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
Natural Products and Dietary Supplements in Alleviation of Metabolic, Cardiovascular, and Neurological Disorders
Metabolic disorders like diabetes, obesity, inflammation, oxidative stress, cancer etc, cardiovascular disorders like angina, myocardial infarction, congestive heart failure etc as well as neurological disorders like Alzheimer?s, Parkinson?s, Epilepsy, Depression, etc are the global burden. They covered the major segment of the diseases and disorders from which the human community ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Scope of Nanotechnology-based Radiation Therapy and Thermotherapy Methods in Cancer Treatment
Current Cancer Drug Targets Targeted Drug Delivery Via Human Epidermal Growth Factor Receptor for Sustained Release of Allyl Isothiocyanate
Current Topics in Medicinal Chemistry Dual Inhibitors of PI3K/mTOR or mTOR-Selective Inhibitors: Which Way Shall We Go?
Current Medicinal Chemistry Combined Treatment with Laser Ablation and Tyrosine-Kinase Inhibitor as A Novel Multimodality Approach to Locally Advanced Thyroid Cancer: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets The mTOR Signaling Pathway is an Emerging Therapeutic Target in Multiple Myeloma
Current Pharmaceutical Design Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Patented Biomarker Panels in Early Detection of Cancer
Recent Patents on Biomarkers Magnetic Resonance Imaging of the Cervix, and its Relevance to the Revised International Federation of Gynecology and Obstetrics (FIGO) Staging
Current Medical Imaging Recent Developments on 1,2,4-Triazole Nucleus in Anticancer Compounds: A Review
Anti-Cancer Agents in Medicinal Chemistry Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Anti-Cancer Effects of a New Docosahexaenoic Acid Monoacylglyceride in Lung Adenocarcinoma
Recent Patents on Anti-Cancer Drug Discovery Genetic and Epigenetic Regulation of Phosphoinositide 3-kinase Isoforms
Current Pharmaceutical Design Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology Evaluation of Blood Pressure Control using a New Arterial Stiffness Parameter, Cardio-ankle Vascular Index (CAVI)
Current Hypertension Reviews Antimicrobial and Anti-Inflammatory Activities of a Leu/Lys-Rich Antimicrobial Peptide with Phe-Peptoid Residues
Protein & Peptide Letters Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets MicroRNAs in Human Virus Genomes: Helping Hands for Viral Infection
MicroRNA Iron Chelators in Cancer Chemotherapy
Current Topics in Medicinal Chemistry Role of Nicotinic Acetylcholine Receptors in Cardiovascular Physiology and Pathophysiology: Current Trends and Perspectives
Current Vascular Pharmacology